Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Testosterone replacement therapy is associated with an increased risk of urolithiasis.

McClintock TR, Valovska MI, Kwon NK, Cole AP, Jiang W, Kathrins MN, Bhojani N, Haleblian GE, Koehlmoos T, Haider AH, Basaria S, Trinh QD.

World J Urol. 2019 Mar 23. doi: 10.1007/s00345-019-02726-6. [Epub ahead of print]

PMID:
30903351
2.

Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.

Rotker KL, Alavian M, Nelson B, Baird GL, Miner MM, Sigman M, Hwang K.

Asian J Androl. 2018 Mar-Apr;20(2):195-199. doi: 10.4103/aja.aja_51_17.

4.

Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets.

Hayden RP, Bennett NE, Tanrikut C.

J Urol. 2016 Dec;196(6):1715-1720. doi: 10.1016/j.juro.2016.05.110. Epub 2016 Jun 7.

PMID:
27287525
5.

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen.

Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI.

Sex Med. 2015 Sep;3(3):165-73. doi: 10.1002/sm2.76. Epub 2015 Aug 12.

6.

Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes.

Carruthers M, Cathcart P, Feneley MR.

Aging Male. 2015;18(4):217-27. doi: 10.3109/13685538.2015.1048218. Epub 2015 Jul 28.

8.

Testosterone treatment is a potent tumor promoter for the rat prostate.

Bosland MC.

Endocrinology. 2014 Dec;155(12):4629-33. doi: 10.1210/en.2014-1688. Epub 2014 Sep 23.

9.

Male contraception.

Chao J, Page ST, Anderson RA.

Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):845-57. doi: 10.1016/j.bpobgyn.2014.05.008. Epub 2014 Jun 5. Review.

10.

An update on male hypogonadism therapy.

Surampudi P, Swerdloff RS, Wang C.

Expert Opin Pharmacother. 2014 Jun;15(9):1247-64. doi: 10.1517/14656566.2014.913022. Epub 2014 Apr 23.

11.

Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.

Kovac JR, Rajanahally S, Smith RP, Coward RM, Lamb DJ, Lipshultz LI.

J Sex Med. 2014 Feb;11(2):553-62. doi: 10.1111/jsm.12369. Epub 2013 Nov 6.

12.

Male contraception: history and development.

Kogan P, Wald M.

Urol Clin North Am. 2014 Feb;41(1):145-61. doi: 10.1016/j.ucl.2013.08.012. Epub 2013 Sep 20. Review.

PMID:
24286773
13.

Subcutaneous pellet testosterone replacement therapy: the "first steps" in treating men with spinal cord injuries.

Gray KM, Derosa A.

J Am Osteopath Assoc. 2013 Dec;113(12):921-5. doi: 10.7556/jaoa.2013.071.

PMID:
24285035
14.

Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.

Conaglen HM, Paul RG, Yarndley T, Kamp J, Elston MS, Conaglen JV.

J Sex Med. 2014 Feb;11(2):574-82. doi: 10.1111/jsm.12401. Epub 2013 Nov 27.

PMID:
24279472
15.

Coadministration of anastrozole sustains therapeutic testosterone levels in hypogonadal men undergoing testosterone pellet insertion.

Mechlin CW, Frankel J, McCullough A.

J Sex Med. 2014 Jan;11(1):254-61. doi: 10.1111/jsm.12320. Epub 2013 Oct 9.

PMID:
24119010
16.

Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism.

Smith RP, Khanna A, Coward RM, Rajanahally S, Kovac JR, Gonzales MA, Lipshultz LI.

J Sex Med. 2013 Sep;10(9):2326-33. doi: 10.1111/jsm.12226. Epub 2013 Jul 16.

PMID:
23859250
17.

Testosterone supplementation does not worsen lower urinary tract symptoms.

Pearl JA, Berhanu D, François N, Masson P, Zargaroff S, Cashy J, McVary KT.

J Urol. 2013 Nov;190(5):1828-33. doi: 10.1016/j.juro.2013.05.111. Epub 2013 Jun 11.

PMID:
23764078
18.

Two innovative pharmaceutical forms of leuprorelin: results from 818 patients with advanced prostate cancer.

Gravel P, Samland D, Löffler M, Maier S, Panozzo M, Muenzberg M.

Adv Ther. 2013 Mar;30(3):271-85. doi: 10.1007/s12325-013-0010-y. Epub 2013 Mar 1.

PMID:
23460040
19.

Testosterone therapy in women: myths and misconceptions.

Glaser R, Dimitrakakis C.

Maturitas. 2013 Mar;74(3):230-4. doi: 10.1016/j.maturitas.2013.01.003. Epub 2013 Feb 4. Review.

20.

Is testosterone treatment good for the prostate? Study of safety during long-term treatment.

Feneley MR, Carruthers M.

J Sex Med. 2012 Aug;9(8):2138-49. doi: 10.1111/j.1743-6109.2012.02808.x. Epub 2012 Jun 6.

PMID:
22672563

Supplemental Content

Loading ...
Support Center